99 related articles for article (PubMed ID: 18155321)
1. Cholinergic regulation of neuropeptide Y synthesis and release in human neuroblastoma cells.
Dozio E; Ruscica M; Feltrin D; Motta M; Magni P
Peptides; 2008 Mar; 29(3):491-5. PubMed ID: 18155321
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic muscarinic mechanisms regulate neuropeptide Y gene expression via protein kinase C in human neuroblastoma cells.
Magni P; Maggi R; Pimpinelli F; Motta M
Brain Res; 1998 Jul; 798(1-2):75-82. PubMed ID: 9666082
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional response to muscarinic acetylcholine receptor stimulation: regulation of Egr-1 biosynthesis by ERK, Elk-1, MKP-1, and calcineurin in carbachol-stimulated human neuroblastoma cells.
Rössler OG; Henss I; Thiel G
Arch Biochem Biophys; 2008 Feb; 470(1):93-102. PubMed ID: 18061571
[TBL] [Abstract][Full Text] [Related]
4. Potentiation of the osmosensitive release of taurine and D-aspartate from SH-SY5Y neuroblastoma cells after activation of M3 muscarinic cholinergic receptors.
Heacock AM; Kerley D; Gurda GT; VanTroostenberghe AT; Fisher SK
J Pharmacol Exp Ther; 2004 Dec; 311(3):1097-104. PubMed ID: 15292461
[TBL] [Abstract][Full Text] [Related]
5. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of neuropeptide Y against β-amyloid 25-35 toxicity in SH-SY5Y neuroblastoma cells is associated with increased neurotrophin production.
Croce N; Dinallo V; Ricci V; Federici G; Caltagirone C; Bernardini S; Angelucci F
Neurodegener Dis; 2011; 8(5):300-9. PubMed ID: 21346312
[TBL] [Abstract][Full Text] [Related]
7. Control of the expression of human neuropeptide Y by leptin: in vitro studies.
Magni P; Vettor R; Pagano C; Calcagno A; Martini L; Motta M
Peptides; 2001 Mar; 22(3):415-20. PubMed ID: 11287096
[TBL] [Abstract][Full Text] [Related]
8. Intracellular signaling mechanisms mediating catecholamine release upon activation of NPY Y1 receptors in mouse chromaffin cells.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Duarte EP; Cavadas C
J Neurochem; 2007 Nov; 103(3):896-903. PubMed ID: 17868303
[TBL] [Abstract][Full Text] [Related]
9. Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide.
Rosmaninho-Salgado J; Araújo IM; Alvaro AR; Mendes AF; Ferreira L; Grouzmann E; Mota A; Duarte EP; Cavadas C
J Neurochem; 2009 May; 109(3):911-22. PubMed ID: 19309436
[TBL] [Abstract][Full Text] [Related]
10. Sodium valproate at therapeutic concentrations changes Ca2+ response accompanied with its weak inhibition of protein kinase C in human astrocytoma cells.
Kurita M; Nishino S; Ohtomo K; Rai M; Shirakawa H; Mashiko H; Niwa S; Nakahata N
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):600-4. PubMed ID: 17258372
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic concentrations of valproate but not amitriptyline increase neuropeptide Y (NPY) expression in the human SH-SY5Y neuroblastoma cell line.
Farrelly LA; Savage NT; O'Callaghan C; Toulouse A; Yilmazer-Hanke DM
Regul Pept; 2013 Sep; 186():123-30. PubMed ID: 23994577
[TBL] [Abstract][Full Text] [Related]
12. Differential thapsigargin-sensitivities and interaction of Ca2+ stores in human SH-SY5Y neuroblastoma cells.
Garavito-Aguilar ZV; Recio-Pinto E; Corrales AV; Zhang J; Blanck TJ; Xu F
Brain Res; 2004 Jun; 1011(2):177-86. PubMed ID: 15157804
[TBL] [Abstract][Full Text] [Related]
13. Expression and precursor processing of neuropeptide Y in human and murine neuroblastoma and pheochromocytoma cell lines.
O'Hare MM; Schwartz TW
Cancer Res; 1989 Dec; 49(24 Pt 1):7015-9. PubMed ID: 2582443
[TBL] [Abstract][Full Text] [Related]
14. Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours.
Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
Br J Cancer; 2000 Jul; 83(2):171-6. PubMed ID: 10901366
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of astaxanthin on 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.
Ikeda Y; Tsuji S; Satoh A; Ishikura M; Shirasawa T; Shimizu T
J Neurochem; 2008 Dec; 107(6):1730-40. PubMed ID: 19014378
[TBL] [Abstract][Full Text] [Related]
16. Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line.
Ankö ML; Panula P
J Neurochem; 2006 Jan; 96(2):573-84. PubMed ID: 16336216
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol regulates volume-sensitive osmolyte efflux from human SH-SY5Y neuroblastoma cells following receptor activation.
Cheema TA; Fisher SK
J Pharmacol Exp Ther; 2008 Feb; 324(2):648-57. PubMed ID: 17991810
[TBL] [Abstract][Full Text] [Related]
18. Retinoic acid negatively regulates neuropeptide Y expression in human neuroblastoma cells.
Magni P; Beretta E; Scaccianoce E; Motta M
Neuropharmacology; 2000 Jul; 39(9):1628-36. PubMed ID: 10854907
[TBL] [Abstract][Full Text] [Related]
19. Characterization of phospholipase D activation by muscarinic receptors in human neuroblastoma SH-SY5Y cells.
Boyano-Adánez MC; Lundqvist C; Larsson C; Gustavsson L
Neuropharmacology; 1997 Mar; 36(3):295-304. PubMed ID: 9175607
[TBL] [Abstract][Full Text] [Related]
20. Activation of muscarinic cholinergic receptors on human SH-SY5Y neuroblastoma cells enhances both the influx and efflux of K+ under conditions of hypo-osmolarity.
Foster DJ; Heacock AM; Keep RF; Fisher SK
J Pharmacol Exp Ther; 2008 May; 325(2):457-65. PubMed ID: 18281593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
